CytoDyn CYDY
OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST

CytoDyn (CYDY) Work In Process (2021 - 2022)

Updated

CytoDyn (CYDY) recorded Work In Process of $63.15 million in fiscal Q3 2022 (quarter ended Feb 28, 2022), down 4.3% from the prior quarter.

Analysis

CytoDyn (CYDY) Work In Process (2021 - 2022) Analysis & Trends

At the end of FY2021 (ended May 31, 2021), CytoDyn reported Work In Process of $65.39 million.

  • Per Business Quant, the preceding three fiscal quarters came in at $66.02 million (Q2 2022), $65.52 million (Q1 2022) and $65.39 million (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CytoDyn 334.50 Mn 285.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2022 63.15 Mn
Nov 30, 2021 66.02 Mn
Aug 31, 2021 65.52 Mn
May 31, 2021 65.39 Mn
API Access

CytoDyn Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=CYDY&period=max&api_key=YOUR_API_KEY